The value of near patient testing is
proven. It reduces costs and improves
the care patients receive.

EARLY DIAGNOSIS & TREATMENT

Physicians across the United States share their knowledge on the importance of
near patient (in-office) clinical testing to their medical practice and the implications
to patient care if they are no longer able to provide these services.

COMMON TESTS PERFORMED NEAR PATIENTS

Vital to diagnosis and treatment of common acute illnesses and disease.

NEAR PATIENT TESTING SAVES LIVES IN RURAL COMMUNITIES

“The results would have been too late. The patient would have died without it.”
Clinician, Rural Kentucky Community

Physicians in rural communities share their views on the value of the near patient testing in their communities as well
as the impact on elderly patients. This research study reveals the unique challenges of elderly patients residing
in our most rural communities in accessing clinical laboratory services.

THREATS

In 2014, Congress passed the Protecting Access to Medicare Act (PAMA) to direct the Centers for Medicare and Medicaid Services (CMS) to develop a market-based methodology for determining the future rates Medicare will pay for tests under the Clinical Laboratory Fee Schedule (CLFS). To date, CMS has collected data from laboratories nationwide who were required to report private payer rates under the PAMA regulations. However, there is widespread concern that the data is fraught with inaccuracies.

Despite these concerns, CMS released the preliminary rate determinations on September 22, 2017 and cuts in routine tests that physicians use every day to diagnosis and treat patients will be even more than projected. Fortunately, physician organizations, led by the American Medical Association, are now lobbying Congress and CMS to ensure that patients continue to receive the benefits of patient testing clinical laboratory testing in their community.

PDF download: Primer on PAMAPAMA Coalition

NEAR PATIENT TESTING
DURING AN OUTBREAK

Our interconnected society makes it vital that our public health professionals get quick, real-time access to diagnostic information when the next epidemic disease breaks out so they can quickly identify the disease and a possible treatment. Physicians who provide laboratory services in their practice are able to rule out other potential infections fast in their own laboratory while the patient waits.  If the infection is not identifiable, the physician can quickly refer the specimen to a reference laboratory or directly to the public health lab. The faster these diseases are identified, the faster we can treat these patients and the more likely we will save their lives.

RECENT NEWS & EVENTS

CMS releases final Clinical Laboratory Fee Schedule

CMS FINAL FEE SCHEDULE WILL HURT PATIENT ACCESS TO CLINICAL LABORATORY

COLUMBIA, MD, November 20, 2017 – The Centers for Medicare and Medicaid Services (CMS) has released its final rates for the Clinical Laboratory Fee Schedule (CLFS) that will phase-in a significant cut in the rates of those common tests physicians use every day to diagnose and treat patients. The first cut is 10% effective January 1, 2018. The…

VIEW ALL NEWS

TWITTER

EMAIL ALERTS

Enter your email address to receive the latest news and information about Near Patient Testing.

EXPLORATIVE RESEARCH STUDY